Key Events This Week
17 Aug: New 52-week and all-time high at Rs.903.15 and Rs.899.95 respectively
18 Aug: Stock declines 0.87% amid broader market weakness
19 Aug: Continued fall of 1.00% with heavy volume
20 Aug: Market recovery with Sensex up 0.63%, stock down 0.81%
21 Aug: Week closes at Rs.871.50, down 0.35% on the day
17 August: Anthem Biosciences Hits New 52-Week and All-Time Highs
On Monday, 17 August 2026, Anthem Biosciences Ltd reached a significant milestone by touching a new 52-week high of Rs.903.15 and an all-time high of Rs.899.95. The stock closed at Rs.898.50, up 0.93% on the day, outperforming the Sensex which declined 0.15% to 36,907.46. This peak reflected a strong bullish momentum supported by the stock trading above all key moving averages and positive technical indicators such as MACD and Bollinger Bands on weekly charts. The company’s one-year total return stood at 8.69%, well ahead of the Sensex’s 3.63% decline over the same period, underscoring its relative strength in a challenging market environment.
18 August: Profit Taking Amid Broader Market Weakness
Following the highs of the previous day, the stock retreated on 18 August, closing at Rs.890.65, down 0.87%. This decline coincided with a broader market sell-off as the Sensex fell 0.43% to 36,749.23. The volume increased significantly to 145,623 shares, indicating active trading and some profit booking after the recent rally. Despite the pullback, the stock remained above key support levels, though the short-term momentum showed signs of weakening.
19 August: Continued Decline on Heavy Volume
On 19 August, Anthem Biosciences experienced a sharper decline, falling 1.00% to close at Rs.881.75. This was accompanied by a surge in volume to 629,577 shares, suggesting intensified selling pressure. The Sensex also declined by 0.47% to 36,577.15, reflecting a cautious market mood. The stock’s technical indicators began to show mild bearishness, with the KST indicator signalling some downward pressure despite the overall bullish weekly MACD. This session marked the steepest daily drop of the week for the stock.
Fresh entry alert! This Small Cap from Electronics & Appliances sector is already turning heads in our Top 1% club. Get ahead of the market now!
- - New Top 1% entry
- - Market attention building
- - Early positioning opportunity
20 August: Market Recovery Fails to Lift Anthem Biosciences
Despite a positive rebound in the Sensex, which gained 0.63% to 36,808.42, Anthem Biosciences continued its downward trend, closing at Rs.874.60, down 0.81%. The volume dropped sharply to 65,022 shares, indicating reduced trading interest. This divergence between the stock and the broader market suggests selective caution among investors, possibly reflecting concerns over recent quarterly financial softness and valuation levels. The stock remained above its 52-week low but below the recent highs, signalling a consolidation phase.
21 August: Week Ends with Minor Losses Amid Market Stability
On the final trading day of the week, Anthem Biosciences closed at Rs.871.50, down 0.35%, while the Sensex was nearly flat, rising 0.02% to 36,814.22. Volume further declined to 53,256 shares, reflecting subdued market activity. The stock’s weekly decline of 2.11% contrasted with the Sensex’s smaller fall of 0.40%, indicating relative underperformance. The week’s price action suggests that the initial enthusiasm following the new highs has given way to profit-taking and cautious positioning ahead of upcoming financial disclosures.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-08-17 | Rs.898.50 | +0.93% | 36,907.46 | -0.15% |
| 2026-08-18 | Rs.890.65 | -0.87% | 36,749.23 | -0.43% |
| 2026-08-19 | Rs.881.75 | -1.00% | 36,577.15 | -0.47% |
| 2026-08-20 | Rs.874.60 | -0.81% | 36,808.42 | +0.63% |
| 2026-08-21 | Rs.871.50 | -0.35% | 36,814.22 | +0.02% |
Key Takeaways from the Week
Positive Signals: Anthem Biosciences demonstrated resilience by hitting new 52-week and all-time highs on 17 August, supported by strong technical indicators and a solid one-year total return of 8.69% versus the Sensex’s decline. The stock’s positioning above all major moving averages and bullish MACD and Bollinger Bands on weekly charts reflect underlying strength.
Cautionary Signals: The subsequent four trading days saw consistent declines, with the stock underperforming the Sensex by 1.71% over the week. Heavy volume on 19 August indicated selling pressure, and recent quarterly financials showed softness in profit before tax and net sales. The Mojo Score of 64.0 and Hold rating reflect a more cautious stance compared to previous Buy grades.
Valuation and Market Context: Despite the rally, valuation multiples remain elevated, with a trailing P/E of 84x and EV/EBITDA of 62.03x, suggesting premium pricing that may limit near-term upside. The stock’s mid-cap status and moderate institutional holdings at 16.05% indicate a balanced market participation profile.
Holding Anthem Biosciences Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Conclusion: A Week of Mixed Momentum and Emerging Caution
Anthem Biosciences Ltd’s week was defined by an initial surge to new highs followed by a steady retreat amid broader market volatility and emerging concerns over valuation and recent financial results. While the stock’s technical foundation remains largely intact, the consistent declines and volume spikes suggest investors are reassessing near-term prospects. The Hold rating and Mojo Score of 64.0 reflect this tempered outlook. Going forward, the stock’s ability to sustain above key support levels and respond to upcoming financial disclosures will be critical for its directional bias.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
